How do we deal with the key challenges of getting patients to participate in clinical research?
Why is patient participation in clinical trials important, especially patients who are traditionally underrepresented?
How will the PIER Consortium help address challenges with conducting clinical trials?
Can we advance research on rare diseases through multi-site collaboration?